University of Pittsburgh Medical Center (UPMC) is a clinical research site located in Pittsburgh, Pennsylvania, United States 15213.
Crixeo Health Trust Score: 87/100 (GOOD). This profile has not yet been claimed by the site owner.
University of Pittsburgh Medical Center (UPMC) has participated in 46 clinical trials with 12 currently active.
Therapeutic areas: BK Virus Infection, Gastric or Gastroesophageal Junction Adenocarcinoma, Pancreatic Ductal Adenocarcinoma.
Sponsors: Vera Therapeutics, Inc., Phanes Therapeutics, Eidos Therapeutics, a BridgeBio company.
Trust Score: 87/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
University of Pittsburgh Medical Center (UPMC) has a Crixeo Trust Score of 87/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Pittsburgh Medical Center (UPMC) has 46 clinical trials on record, with 12 currently active. Their work covers BK Virus Infection, Gastric or Gastroesophageal Junction Adenocarcinoma, Pancreatic Ductal Adenocarcinoma.
University of Pittsburgh Medical Center (UPMC) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.